Chicken Soup for the Soul Entertainment’s Crackle Plus Announces New Slate of Original Programming, and the Launch of a New Chicken Soup for the Soul AVOD Network at 2021 NewFronts

Written by Customer Service on May 3, 2021. Posted in Public Companies.

Upcoming Slate of Original Content Includes New Sports Docu-series ‘Promiseland’ and ‘Vince Carter: Legacy’, Featuring Respectively Ja Morant and Vince Carter, and The Unscripted Show ‘Inside the Black Box’, Which Explores the Role Race Plays In The Entertainment Industry Publishing Megabrand ‘Chicken Soup for The Soul’ To Bring Its Original Mission Of “Changing the World One Story at The Time” To A New Streaming Network In The Fall COS COB, Conn., May 03, 2021 (GLOBE NEWSWIRE) — Crackle Plus, a Chicken Soup for the Soul Entertainment, Inc. (Nasdaq: CSSE) company and one of the largest operators of streaming advertising-supported video-on-demand (AVOD) networks, made multiple announcements today during its NewFronts presentation, including a diverse new slate of original and exclusive programming, and the launch of a new...

NewAge Launches New Children’s Multivitamin With Better Absorption for Immune System Support

Written by Customer Service on May 3, 2021. Posted in Public Companies.

DENVER, May 03, 2021 (GLOBE NEWSWIRE) — NewAge, Inc., the Colorado-based organic and healthy products company intending to become the world’s leading social selling and distribution company, announced today the launch of Nutrifii Kids™ Chewable Multivitamin, a daily supplement for support of the healthy development and immune systems of children and adolescents. According to the World Health Organization (WHO), school-age children, adolescents and adults are eating too many sugary foods and drinks and refined grains, and not enough foods that promote health such as fruits, vegetables, and whole grains. About 30% of all school-age children do not eat any fruit daily, yet over 40% of children consume a soft drink every day. New analysis of over 23,000 consumer packaged food products shows 69% are of relatively poor nutrient quality. The...

Image Sensing Systems, Inc. Announces 2021 First Quarter Results

Written by Customer Service on May 3, 2021. Posted in Public Companies.

SAINT PAUL, Minn., May 03, 2021 (GLOBE NEWSWIRE) — Image Sensing Systems, Inc. (Nasdaq: ISNS) today announced results for its quarter ended March 31, 2021. First Quarter 2021 Financial Summary First quarter royalties were $1.8 million, a decrease of 14 percent from the same period in the prior year. First quarter product sales were $1.2 million, an increase of 11 percent from the same period in the prior year. Operating expenses totaled $1.9 million in the first quarter of 2021, a decrease of 34 percent from the prior year period. Capitalized software costs in the first quarter of 2021 were $123,000 compared to $22,000 in the prior year period. The Company recognized other income of $931,000 for the forgiveness of the Paycheck Protection Program loan and accrued interest during the first quarter. Net income for the first quarter...

Arcutis to Present New Roflumilast Cream Phase 3 Data at The European Academy of Dermatology and Venereology (EADV) Spring Symposium

Written by Customer Service on May 3, 2021. Posted in Public Companies.

Presentation will highlight efficacy and safety data from the DERMIS-1 and DERMIS-2 pivotal Phase 3 studies evaluating roflumilast cream (ARQ-151) as a potential topical once-daily treatment for chronic plaque psoriasis WESTLAKE VILLAGE, Calif., May 03, 2021 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, will present efficacy and safety data from the DERMIS-1 and DERMIS-2 pivotal Phase 3 studies evaluating roflumilast cream (ARQ-151) as a potential once-daily topical treatment for chronic plaque psoriasis at the European Academy of Dermatology and Venereology (EADV) Spring Symposium May 6 – May 7, 2021. “The EADV symposium...

Tarsus Pharmaceuticals, Inc. Presents Results of Pioneering Atlas Study at ARVO 2021 Annual Meeting Demonstrating the Functional and Psychosocial Impact of Demodex Blepharitis

Written by Customer Service on May 3, 2021. Posted in Public Companies.

Demodex blepharitis is a common ocular condition that may affect up to 25 million Americans Atlas study shows that Demodex blepharitis negatively impacts daily life for 80 percent of patients Tarsus also presents complete efficacy and safety data from Phase 2b Europa trial, positive trial results used as the basis for the Saturn-1 & 2 pivotal trials IRVINE, Calif., May 03, 2021 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a late clinical-stage biopharmaceutical company whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, today announced data from its Demodex blepharitis clinical program presented at the virtual Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting. Demodex blepharitis...

Tower One Announces Filing of its Q4 and Year 2020 Annual Report

Written by Customer Service on May 3, 2021. Posted in Public Companies.

VANCOUVER, British Columbia, May 03, 2021 (GLOBE NEWSWIRE) — TOWER ONE WIRELESS CORP. (CSE: TO) (OTCQB: TOWTF) (Frankfurt: 1P3N) (“Tower One” or the “Company”) filed its financial results for the fourth quarter of 2020 and full year ended December 31, 2020, and the related Management’s Discussion and Analysis; details of which are available on the System for Electronic Document Analysis and Retrieval (SEDAR) at www.sedar.com https://sedar.com/GetFile.do?lang=EN&docClass=5&issuerNo=00029863&issuerType=03&projectNo=03213922&docId=4948333 Highlights year 2020: Revenue increased to CAD$9,126,082 for the year 2020 as compared to CAD$5,413,594 for the year 2019 and CAD$1,556,742 for the year 2018 representing a 486% increase over the last two years. Revenue increase is a result of (i) additional towers that...

Entasis Therapeutics Completes Initial Closing of $20M Private Placement with Innoviva

Written by Customer Service on May 3, 2021. Posted in Mergers And Acquisitions.

WALTHAM, Mass., May 03, 2021 (GLOBE NEWSWIRE) — Entasis Therapeutics Holdings Inc. (Nasdaq: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, announced today that it has completed the initial closing of an approximately $7.5 million stock and warrant issuance to a subsidiary of Innoviva Inc. (Nasdaq: INVA) (“Innoviva”), pursuant to a securities purchase agreement signed on May 3, 2021. Upon satisfaction of certain closing conditions, including approval by Entasis stockholders, Innoviva will purchase the balance of the $20 million in Entasis common stock and warrant securities in a second closing that is anticipated later in the second quarter of 2021 (excluding the consideration payable upon exercise of warrants, if any). Entasis plans to use...

CNB Financial Announces Quarterly Dividend for Series A Preferred Stock and Related Depositary Shares Distribution

Written by Customer Service on May 3, 2021. Posted in Dividend Reports And Estimates.

CLEARFIELD, Pa., May 03, 2021 (GLOBE NEWSWIRE) — The Board of Directors of CNB Financial Corporation (Nasdaq: CCNE) (the “Corporation”) has announced the declaration of a quarterly cash dividend of $0.4453125 per depositary share, resulting from the Corporation’s declaration of a $17.8125 per share dividend on its Series A Preferred Stock. The dividend is payable on June 1, 2021, for holders of record as of May 18, 2021. CNB Financial Corporation is a financial holding company with consolidated assets of approximately $4.9 billion. CNB Financial Corporation conducts business primarily through its principal subsidiary, CNB Bank. CNB Bank is a full-service bank engaging in a full range of banking activities and services, including trust and wealth management services, for individual, business, governmental, and institutional...

Emergia Inc. Announces Closing of the Acquisition of a Land for Development in Alliston, Ontario

Written by Customer Service on May 3, 2021. Posted in Mergers And Acquisitions.

MONTREAL, May 03, 2021 (GLOBE NEWSWIRE) — (CSE: EMER) Emergia Inc. (the “Corporation” or “EMERGIA”) is pleased to announce that it has closed today, May 3, 2021, its previously announced potential acquisition of a land of approximately 100 acres in Alliston, Ontario for a purchase price of $14.4 million (excluding closing costs and a reserve for interests and pre-development costs). The acquisition of the land was done at arm’s length and the purchase price was paid as follows: (i) $9,600,000 in cash and (ii) $4,800,000 in Class A shares of the Corporation at the issuance price of $1.00 per share of which 300,000 have been issued and 4,500,000 are reserved for issuance upon receipt of the allocation of such shares between the vendors. To satisfy a portion of the purchase price, the Corporation entered into a financing of $9,000,000...

Intema to Acquire Leading Esports Betting Platform LOOT.BET

Written by Customer Service on May 3, 2021. Posted in Mergers And Acquisitions.

Intema signs letter of intent to acquire Livestream Gaming Ltd, Belize. Livestream Gaming owns LOOT.BET esports bookmaker platform, a world leader in esports betting. LOOT.BET betting handle was 62.2 million euros (CA$92.2 million) for the year ended December 31, 2020. Acquisition to be accretive to Intema’s revenues: Livestream Gaming recorded unaudited gross gaming revenue of 3.2 million euros (CA$4.8 million) and a net profit of 79,806 euros (CA$114,792) for the year ended December 31, 2020. Esports market projected to reach US$1.86 billion by 2026 at a CAGR of 15.1%1. MONTREAL, May 03, 2021 (GLOBE NEWSWIRE) — Intema Solutions Inc. (“Intema” or the “Corporation”) (TSXV: ITM, OTCMKTS: ITMZF) is pleased to announce that it entered into an arm’s length binding letter of intent (the “LOI”) dated April 30, 2021 with Livestream...

Day: May 3, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice